Extendicare Valuation
| EXE Stock | CAD 23.89 0.70 3.02% |
At this time, the firm appears to be undervalued. Extendicare shows a prevailing Real Value of C$25.82 per share. The current price of the firm is C$23.89. Our model computes the value of Extendicare from reviewing the firm fundamentals such as Shares Outstanding of 94.46 M, profit margin of 0.06 %, and Current Valuation of 2.38 B as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Extendicare's valuation include:
Price Book 13.4456 | Enterprise Value | Enterprise Value Ebitda 13.4977 | Price Sales 1.4193 | Forward PE 21.2314 |
Undervalued
Today
Please note that Extendicare's price fluctuation is very steady at this time. Calculation of the real value of Extendicare is based on 3 months time horizon. Increasing Extendicare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Extendicare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Extendicare Stock. However, Extendicare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.89 | Real 25.82 | Hype 23.89 | Naive 23.66 |
The intrinsic value of Extendicare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Extendicare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Extendicare helps investors to forecast how Extendicare stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Extendicare more accurately as focusing exclusively on Extendicare's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Extendicare's intrinsic value based on its ongoing forecasts of Extendicare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Extendicare's closest peers.
Extendicare Cash |
|
Extendicare Total Value Analysis
Extendicare is currently forecasted to have takeover price of 2.38 B with market capitalization of 2.26 B, debt of 292.49 M, and cash on hands of 121.85 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Extendicare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.38 B | 2.26 B | 292.49 M | 121.85 M |
Extendicare Investor Information
About 35.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 30th of January 2026. Extendicare had 43:40 split on the 10th of November 2006. Based on the measurements of operating efficiency obtained from Extendicare's historical financial statements, Extendicare is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0769 | 0.0872 |
|
| |||||
| Operating Income | 90.1 M | 100.1 M |
|
|
Extendicare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Extendicare has an asset utilization ratio of 203.7 percent. This suggests that the Company is making C$2.04 for each dollar of assets. An increasing asset utilization means that Extendicare is more efficient with each dollar of assets it utilizes for everyday operations.Extendicare Profitability Analysis
Based on the measurements of profitability obtained from Extendicare's financial statements, Extendicare is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in March. Profitability indicators assess Extendicare's ability to earn profits and add value for shareholders.Net Income | First Reported 2003-03-31 | Previous Quarter 31.9 M | Current Value 24.1 M | Quarterly Volatility 27.3 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.13 | 0.1146 |
|
| |||||
| Operating Profit Margin | 0.0769 | 0.0872 |
|
|
For Extendicare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Extendicare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Extendicare utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Extendicare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Extendicare over time as well as its relative position and ranking within its peers.
Extendicare Earnings per Share Projection vs Actual
By analyzing Extendicare's earnings estimates, investors can diagnose different trends across Extendicare's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Extendicare is based on EPS before non-recurring items and includes expenses related to employee stock options.Extendicare Ownership Allocation
Extendicare holds a total of 94.46 Million outstanding shares. 30% of Extendicare outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Extendicare Profitability Analysis
The company reported the revenue of 1.47 B. Net Income was 75.21 M with profit before overhead, payroll, taxes, and interest of 227.52 M.Extendicare Past Distributions to stockholders
About Extendicare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Extendicare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Extendicare based exclusively on its fundamental and basic technical indicators. By analyzing Extendicare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Extendicare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Extendicare. We calculate exposure to Extendicare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Extendicare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 151.2 M | 143.6 M | |
| Pretax Profit Margin | 0.06 | 0.06 | |
| Operating Profit Margin | 0.09 | 0.08 | |
| Net Profit Margin | 0.05 | 0.05 | |
| Gross Profit Margin | 0.11 | 0.13 |
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help investors to determine whether Extendicare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Extendicare with respect to the benefits of owning Extendicare security.